Cost Effectiveness of Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for the First-Line Treatment of Mantle Cell Lymphoma Not Eligible for Stem Cell Transplantation: A Scottish Perspective

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.1147
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Durable Remission of Mantle Cell Lymphoma Relapsing a Third Time After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Rituximab, Bortezomib, Donor Lymphocytes, and Pegylated Interferon

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma

British Journal of Haematology
Hematology
2015English

Economics of Stem Cell Transplantation for Lymphoma: Counting the Cost of Living

British Journal of Cancer
Cancer ResearchOncology
2000English

Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply

The Lancet Oncology
Oncology
2017English

Role of Radiotherapy in Diffuse Large B‐cell Lymphoma in Advanced Stages on Complete Response After Administration of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab

Precision Radiation Oncology
2019English

Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Adults With Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Retrospective Analysis in the Rituximab Era

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Stem Cell Transplantation for Mantle Cell Lymphoma: Should It Ever Be Used Outside Clinical Trials?

Bone Marrow Transplantation
TransplantationHematology
2001English

Emerging Therapy for the Treatment of Mantle Cell Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2014English

Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free and Overall Survival in Mantle Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy